A new symptom on a long-running claim is usually treated as a new problem. Sometimes it is the predictable effect of a medicine the worker is already taking, and the decision to treat it as something new sets the claim on a longer and more expensive path.
Medication Risk
Why does an adverse drug reaction look like a new condition on a claim file?
Claims files are built around events. An injury happens, treatment follows, and each new request for treatment arrives attached to a diagnosis. The structure works well for injuries and poorly for medicines, because the effects of a medicine do not arrive as an event. They arrive as a symptom, and a symptom needs a name before anyone will fund anything for it.
Australian Prescriber describes the consequence precisely. A prescribing cascade occurs when a new medicine is prescribed to treat an adverse reaction to another drug, in the mistaken belief that a new medical condition requiring treatment has developed (Kalisch, Caughey, Roughead and Gilbert, Aust Prescr 2011;34:162-6). The same paper notes that harm follows in two directions. The second medicine can worsen the reaction to the first, or it can expose the person to a fresh set of adverse effects of its own. Prevention, the authors conclude, depends on avoidance, early detection and increased awareness rather than on any single clever intervention.
On a workers compensation or CTP file the mistaken belief has a second life. It does not only change the prescribing. It creates a documented condition, which creates funded treatment, which can create a secondary condition claim, a capacity change and a certificate that no longer matches the original injury.
Which symptom clusters are most often misread?
The patterns that cause trouble on injury claims are not obscure. They are common, well described in the approved Product Information for the medicines involved, and easy to attribute to the injury or to the worker's psychological state instead.
| Symptom on the file | Commonly involved medicine groups | The question to ask first |
|---|---|---|
| Low mood, flat affect, tearfulness | Opioids, some antihypertensives, corticosteroids, gabapentinoids | Did the mood change track a dose change rather than a life event or a claim event? |
| Poor concentration, word-finding trouble, described as cognitive decline | Opioids, benzodiazepines, gabapentinoids, sedating antihistamines, some anticonvulsants | Is the worker taking two or more sedating agents together? |
| Falls, unsteadiness, a new injury on top of the old one | Sedatives, opioids, antihypertensives, anticholinergics | Was the total sedative load reviewed after the last increase? |
| Reflux, nausea, abdominal pain | Non-steroidal anti-inflammatory drugs, opioids, some antidepressants | Is a new acid suppressant being added to hold an analgesic in place? |
| Insomnia, agitation, restlessness | Corticosteroids, some antidepressants, stimulants, withdrawal from sedatives | Is this a new sleep disorder or an effect of a recent medicine change? |
| Constipation, then bowel investigations | Opioids, anticholinergics | Was a laxative reviewed, or simply added and left? |
| Swelling, weight gain, breathlessness | Gabapentinoids, corticosteroids, some antidepressants | Does the onset line up with the start of the medicine? |
None of these mean the worker does not have a new condition. Plenty do. They mean that a claims file which accepts a new condition without a medication explanation having been ruled out is carrying an unexamined risk.
What does the scheme expect before a new condition is accepted?
Insurers make two separate decisions about a medicine or a treatment request. The first is whether it relates to the compensable injury. The second is whether it is reasonably necessary, or in the NSW reformed language reasonable and necessary, in the circumstances. Scheme guidance, including the SIRA Workers Compensation Guidelines and the medical guidance that sits beneath them, expects those decisions to rest on evidence rather than on the sequence of documents in the file.
That matters here because a misread adverse drug reaction contaminates both decisions. A condition caused by a medicine prescribed for the injury may well be claim related, but the treatment that resolves it is usually a change to the original medicine rather than a second medicine layered on top. Funding the second medicine without asking the first question means funding something that is unlikely to be reasonably necessary, and doing so indefinitely.
What is the clinical risk if the misreading stands?
The risk compounds. A worker who is sedated by two agents and then given a third for low mood has a higher fall risk, a lower chance of engaging with active rehabilitation and a certificate that is harder to upgrade. Investigations for a symptom that has a pharmacological cause return normal results, which encourages more investigation rather than less. The worker is told repeatedly that nothing is wrong, which erodes trust in the treatment team and in the insurer.
The recovery cost is usually larger than the drug cost. Rehabilitation depends on a worker who can attend, concentrate and tolerate activity. Medicines that undermine those three things slow return to work regardless of how well the rest of the claim is managed.
What should a claims manager check first?
Before a new condition is accepted and before new treatment is approved for a new symptom, the file should be able to answer five questions.
- What is the complete current medicine list, including over the counter and privately prescribed items, and when did each one start?
- Did the new symptom begin within a plausible window of a start, an increase or a cessation?
- Is the symptom a recognised effect of anything on the list, according to the approved Product Information?
- Has anyone asked the treating doctor that question directly, and is the answer on the file?
- If a medicine is the likely cause, what is the plan to change it, and who is monitoring the result?
The fourth question is the one that is usually missing. A medicine list on a file is not a review. Someone with the pharmacology has to look at the sequence, form a view, put it to the prescriber and record what was agreed.
How should the file record the answer?
Record the reasoning, not just the outcome. A note that says the new symptom was considered against the current regimen, that the treating doctor was contacted on a stated date, and that the medicine was retained or changed for a stated reason, protects the decision if it is later reviewed or disputed. A note that says a new condition was accepted on the basis of a certificate does not.
Key Takeaways
- A prescribing cascade begins when an adverse drug reaction is mistaken for a new condition and a second medicine is added to treat it (Australian Prescriber, 2011).
- Timing is the most useful single test. Symptoms that follow a start, an increase or a cessation deserve a medication explanation first.
- Mood change, cognitive slowing, falls, gastrointestinal symptoms and insomnia are the clusters most often misattributed on injury claims.
- Accepting a new condition without ruling out a medication cause affects both the claim relatedness and the reasonably necessary decisions.
- A medicine list on a file is not a review. The prescriber question has to be asked and the answer recorded.
Frequently Asked Questions
Is an adverse drug reaction to a funded medicine a compensable condition?
Often yes, where the medicine was prescribed for the compensable injury, but that is a liability question for the insurer on the facts and the applicable scheme rules. The clinical point is separate. The appropriate response to an adverse reaction is usually a change to the medicine causing it rather than a new medicine added on top.
Can a claims manager make this call without clinical input?
No. A claims manager can and should notice the timing pattern and ask for it to be assessed. The attribution itself, and any recommendation to the prescriber, needs a clinician who can weigh the pharmacology and the worker's full regimen.
What if the treating doctor disagrees that the medicine is the cause?
That is a legitimate clinical difference and the file should record both positions and the reasoning behind each. Independent pharmacist review is useful precisely because it puts the question in writing, with the evidence attached, so the decision is made openly rather than by default.
When is the best time to ask the question on a claim?
As early as the first new symptom that does not obviously belong to the injury. The longer a cascade runs, the more medicines are involved, the harder any change becomes and the more the worker's capacity is affected.
Does this apply to CTP claims as well as workers compensation?
Yes. The pharmacology does not change with the scheme. The decision framework differs across jurisdictions, but the need to separate an adverse drug reaction from a new condition before funding treatment for it is the same.
Sources: Kalisch LM, Caughey GE, Roughead EE, Gilbert AL, "The prescribing cascade", Australian Prescriber 2011;34:162-6; Therapeutic Goods Administration approved Product Information for the medicine classes referenced; State Insurance Regulatory Authority (NSW) Workers Compensation Guidelines and associated medical guidance. Reviewed 21/09/2026.
